Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Plos One|April 22, 2014
Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery diseaseJosé Tuñón, Carmen Cristóbal, Nieves Tarín, et al.Plos One|January 20, 2017
Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery DiseaseAna María Pello Lázaro, Carmen Cristóbal, Juan Antonio Franco-Peláez, et al.Diabetes/Metabolism Research and Reviews|February 19, 2016
Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery diseaseJosé Tuñón, Beatriz Fernández-Fernández, Rocío Carda, et al.ESC Heart Failure|July 24, 2024
Bioimpedance analysis predicts worsening events in outpatients with heart failure and reduced ejection fractionCarlos Rodríguez-López, Jorge Balaguer Germán, Ana Venegas Rodríguez, et al.Journal of Bone and Mineral Metabolism|August 24, 2015
Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rateEmilio González-Parra, Álvaro Aceña, Óscar Lorenzo, et al.Plos One|May 13, 2016
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery DiseaseRoberto Martín-Reyes, Juan Antonio Franco-Peláez, Óscar Lorenzo, et al.Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|August 17, 2014
[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease]Javier Higueras, José Luis Martín-Ventura, Luis Blanco-Colio, et al.Journal of Cardiology|December 24, 2014
Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factorsAna María Pello, Carmen Cristóbal, Nieves Tarín, et al.BMJ Open|August 7, 2016
Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trialJosé Tuñón, Ignacio González-Hernández, Lucía Llanos-Jiménez, et al.Pageof 2